Scott M. Schuetze
University of Michigan(US)University of Michigan–Ann Arbor(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Vascular Tumors and Angiosarcomas, Lymphoma Diagnosis and Treatment, Cardiac tumors and thrombi, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial(2017)1,375 cited
- → NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors(2010)1,215 cited
- → Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology(2022)1,120 cited
- → Integrative clinical genomics of metastatic cancer(2017)918 cited
- → Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial(2015)817 cited
- → Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing(2013)810 cited